CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Phosphoproteins

Subtype terms (29)

More specific conditions that are subtypes of Phosphoproteins in the MeSH hierarchy.

  • bcl-Associated Death Protein
  • BRCA1 Protein

    67 drugs (47 approved, 20 experimental)

  • Caseins

    2 drugs experimental

  • Caveolin 1
  • Caveolin 2
  • CDC2 Protein Kinase
  • Cortactin
  • Crk-Associated Substrate Protein
  • Dentin Sialophosphoprotein
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Fanconi Anemia Complementation Group A Protein
  • Fanconi Anemia Complementation Group D2 Protein
  • Fanconi Anemia Complementation Group G Protein
  • Focal Adhesion Kinase 1
  • Integrin-Binding Sialoprotein
  • Interferon Regulatory Factor-3
  • Interferon Regulatory Factor-7
  • Paxillin
  • Phosvitin
  • Plectin
  • Retinoblastoma-Like Protein p107
  • Retinoblastoma-Like Protein p130
  • Retinoblastoma Protein
  • Smad Proteins, Receptor-Regulated
  • Stathmin
  • Synapsins
  • Tumor Suppressor Protein p53

    33 drugs (28 approved, 5 experimental)

  • Vitellogenins
  • Zyxin

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.